Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Corning Inc. Stock Falls 13.7%, Underperforms Peers

Corning Inc. Stock Falls 13.7%, Underperforms Peers

Dow JonesDow Jones2026/09/14 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corning Inc. tumbled 13.7% to $143.60 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,619.98 and Dow Jones Industrial Average falling 0.3% to 52,421.20.

Corning Inc. closed 47.2% short of its 52-week high of $271.78, which the company reached on June 30th.

The stock underperformed when compared to some of its peers, as Thermo Fisher Scientific Inc. rose 0.6% to $613.62, Danaher Corp. rose 1.6% to $203.25, and Vistance Networks Inc. fell 0.23% to $6.47.

Trading volume totaled 17.6 million, compared to the 50-day average of 11.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 14, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage